Cancer Epigenetics: Clinical Perspectives
Journal:
Current Cancer Drug Targets
Volume:
19
Page:
513-514
Author(s):
Aamir Ahmad
Meet Our Editorial Board Member
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
14
Page:
99-99
Author(s):
Olivier Micheau
Inhibitory Effect of Hydroxysafflor Yellow B on the Proliferation of Human Breast Cancer MCF-7 Cells
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
14
Page:
187-197
Author(s):
Chuanjun Qu, Weiwei Zhu, Kaijie Dong, Zhaohai Pan, Ying Chen, Xiaoyu Chen, Xiaona Liu, Wenjuan Xu, Haiyan Lin, Qiusheng Zheng* and Defang Li*
A Truncated Snail1 Transcription Factor Alters the Expression of Essential EMT Markers and Suppresses Tumor Cell Migration in a Human Lung Cancer Cell Line
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
14
Page:
158-169
Author(s):
Mohammad Davoodzadeh Gholami, Reza Falak*, Sahel Heidari, Majid Khoshmirsafa, Mohammad H. Kazemi, Amir-Hassan Zarnani, Elaheh Safari, Nader Tajik and Gholam A. Kardar*
Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells
Journal:
Current Cancer Drug Targets
Volume:
19
Page:
571-582
Author(s):
Jia Wei, Ling Ma, Chenglong Li, Christopher R. Pierson, Jonathan L. Finlay and Jiayuh Lin*
Interactions of Vascular Endothelial Growth Factor and p53 with miR-195 in Thyroid Carcinoma: Possible Therapeutic Targets in Aggressive Thyroid Cancers
Journal:
Current Cancer Drug Targets
Volume:
19
Page:
561-570
Author(s):
Hamidreza Maroof, Soussan Irani, Armin Arianna, Jelena Vider, Vinod Gopalan and Alfred King-yin Lam*
Death-Associated Protein Kinase 1 as a Promising Drug Target in Cancer and Alzheimer’s Disease
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
14
Page:
144-157
Author(s):
Dongmei Chen, Xiao Z. Zhou* and Tae H. Lee*
Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal Cancer
Journal:
Current Cancer Drug Targets
Volume:
19
Page:
534-550
Author(s):
Gang Wang, Jun-Jie Wang, Rui Guan, Yan Sun, Feng Shi, Jing Gao* and Xing-Li Fu*
Novel Small Molecule Inhibitors of Programmed Cell Death (PD)-1, and its Ligand, PD-L1 in Cancer Immunotherapy: A Review Update of Patent Literature
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
14
Page:
100-112
Author(s):
Spandana R. Kopalli, Tae-Bong Kang, Kwang-Ho Lee and Sushruta Koppula*
Xiao-Chai-Hu-Tang (XCHT) Intervening Irinotecan’s Disposition: The Potential of XCHT in Alleviating Irinotecan-Induced Diarrhea
Journal:
Current Cancer Drug Targets
Volume:
19
Page:
551-560
Author(s):
Rongjin Sun, Sumit Basu, Min Zeng, Robin Sunsong, Li Li, Romi Ghose, Wei Wang, Zhongqiu Liu, Ming Hu* and Song Gao*